Logo image of INS.DE

INSTONE REAL ESTATE GROUP SE (INS.DE) Stock Fundamental Analysis

Europe - FRA:INS - DE000A2NBX80 - Common Stock

8.99 EUR
+0.21 (+2.39%)
Last: 10/20/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to INS. INS was compared to 72 industry peers in the Real Estate Management & Development industry. Both the profitability and the financial health of INS get a neutral evaluation. Nothing too spectacular is happening here. INS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year INS was profitable.
In the past year INS had a positive cash flow from operations.
INS had positive earnings in each of the past 5 years.
INS had a positive operating cash flow in each of the past 5 years.
INS.DE Yearly Net Income VS EBIT VS OCF VS FCFINS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

INS has a Return On Assets (1.36%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 4.71%, INS is in the better half of the industry, outperforming 61.11% of the companies in the same industry.
With a decent Return On Invested Capital value of 2.76%, INS is doing good in the industry, outperforming 65.28% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for INS is in line with the industry average of 3.90%.
Industry RankSector Rank
ROA 1.36%
ROE 4.71%
ROIC 2.76%
ROA(3y)1.66%
ROA(5y)2.61%
ROE(3y)5.3%
ROE(5y)7.29%
ROIC(3y)4.38%
ROIC(5y)5.76%
INS.DE Yearly ROA, ROE, ROICINS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

INS has a Profit Margin (6.99%) which is in line with its industry peers.
INS's Profit Margin has declined in the last couple of years.
INS has a Operating Margin of 10.76%. This is comparable to the rest of the industry: INS outperforms 55.56% of its industry peers.
In the last couple of years the Operating Margin of INS has declined.
The Gross Margin of INS (25.90%) is comparable to the rest of the industry.
INS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.76%
PM (TTM) 6.99%
GM 25.9%
OM growth 3Y-11.37%
OM growth 5Y-7.83%
PM growth 3Y-13.8%
PM growth 5Y-12.12%
GM growth 3Y-3.52%
GM growth 5Y-4.26%
INS.DE Yearly Profit, Operating, Gross MarginsINS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), INS is destroying value.
INS has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for INS has been increased compared to 5 years ago.
Compared to 1 year ago, INS has an improved debt to assets ratio.
INS.DE Yearly Shares OutstandingINS.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
INS.DE Yearly Total Debt VS Total AssetsINS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 1.17, we must say that INS is in the distress zone and has some risk of bankruptcy.
INS's Altman-Z score of 1.17 is in line compared to the rest of the industry. INS outperforms 59.72% of its industry peers.
INS has a debt to FCF ratio of 6.71. This is a slightly negative value and a sign of low solvency as INS would need 6.71 years to pay back of all of its debts.
INS's Debt to FCF ratio of 6.71 is fine compared to the rest of the industry. INS outperforms 79.17% of its industry peers.
A Debt/Equity ratio of 0.69 indicates that INS is somewhat dependend on debt financing.
INS has a Debt to Equity ratio (0.69) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 6.71
Altman-Z 1.17
ROIC/WACC0.5
WACC5.48%
INS.DE Yearly LT Debt VS Equity VS FCFINS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 2.03 indicates that INS has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.03, INS is in the better half of the industry, outperforming 63.89% of the companies in the same industry.
A Quick Ratio of 0.72 indicates that INS may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.72, INS is in line with its industry, outperforming 47.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 0.72
INS.DE Yearly Current Assets VS Current LiabilitesINS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 32.58% over the past year.
Measured over the past years, INS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.52% on average per year.
The Revenue for INS has decreased by -20.30% in the past year. This is quite bad
The Revenue has been decreasing by -3.13% on average over the past years.
EPS 1Y (TTM)32.58%
EPS 3Y-25.87%
EPS 5Y-16.52%
EPS Q2Q%-75.18%
Revenue 1Y (TTM)-20.3%
Revenue growth 3Y-16.3%
Revenue growth 5Y-3.13%
Sales Q2Q%-18.28%

3.2 Future

Based on estimates for the next years, INS will show a very strong growth in Earnings Per Share. The EPS will grow by 30.79% on average per year.
Based on estimates for the next years, INS will show a small growth in Revenue. The Revenue will grow by 6.30% on average per year.
EPS Next Y-4.12%
EPS Next 2Y20.54%
EPS Next 3Y20.37%
EPS Next 5Y30.79%
Revenue Next Year-11.66%
Revenue Next 2Y4.69%
Revenue Next 3Y6.3%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
INS.DE Yearly Revenue VS EstimatesINS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
INS.DE Yearly EPS VS EstimatesINS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.27, INS is valued correctly.
72.22% of the companies in the same industry are more expensive than INS, based on the Price/Earnings ratio.
INS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.69.
Based on the Price/Forward Earnings ratio of 9.01, the valuation of INS can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of INS indicates a rather cheap valuation: INS is cheaper than 87.50% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of INS to the average of the S&P500 Index (23.18), we can say INS is valued rather cheaply.
Industry RankSector Rank
PE 14.27
Fwd PE 9.01
INS.DE Price Earnings VS Forward Price EarningsINS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

84.72% of the companies in the same industry are more expensive than INS, based on the Enterprise Value to EBITDA ratio.
INS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. INS is cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.11
EV/EBITDA 11.73
INS.DE Per share dataINS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

INS's earnings are expected to grow with 20.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.54%
EPS Next 3Y20.37%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.73%, INS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 7.52, INS pays a better dividend. On top of this INS pays more dividend than 84.72% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, INS pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.73%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
INS.DE Yearly Dividends per shareINS.DE Yearly Dividends per shareYearly Dividends per share 2022 2024 2025 0.2 0.4 0.6

5.3 Sustainability

INS pays out 79.32% of its income as dividend. This is not a sustainable payout ratio.
DP79.32%
EPS Next 2Y20.54%
EPS Next 3Y20.37%
INS.DE Yearly Income VS Free CF VS DividendINS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M
INS.DE Dividend Payout.INS.DE Dividend Payout, showing the Payout Ratio.INS.DE Dividend Payout.PayoutRetained Earnings

INSTONE REAL ESTATE GROUP SE

FRA:INS (10/20/2025, 7:00:00 PM)

8.99

+0.21 (+2.39%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-07 2025-08-07
Earnings (Next)11-06 2025-11-06
Inst Owners34.13%
Inst Owner ChangeN/A
Ins Owners0.38%
Ins Owner ChangeN/A
Market Cap422.44M
Analysts82.22
Price Target13.12 (45.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.73%
Yearly Dividend0.33
Dividend Growth(5Y)N/A
DP79.32%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4.55%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-6.59%
EPS NY rev (3m)-4.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 14.27
Fwd PE 9.01
P/S 1.08
P/FCF 5.11
P/OCF 5.11
P/B 0.73
P/tB 0.74
EV/EBITDA 11.73
EPS(TTM)0.63
EY7.01%
EPS(NY)1
Fwd EY11.1%
FCF(TTM)1.76
FCFY19.56%
OCF(TTM)1.76
OCFY19.57%
SpS8.32
BVpS12.33
TBVpS12.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.36%
ROE 4.71%
ROCE 3.97%
ROIC 2.76%
ROICexc 4.62%
ROICexgc 4.66%
OM 10.76%
PM (TTM) 6.99%
GM 25.9%
FCFM 21.14%
ROA(3y)1.66%
ROA(5y)2.61%
ROE(3y)5.3%
ROE(5y)7.29%
ROIC(3y)4.38%
ROIC(5y)5.76%
ROICexc(3y)6.6%
ROICexc(5y)7.56%
ROICexgc(3y)6.66%
ROICexgc(5y)7.63%
ROCE(3y)6.3%
ROCE(5y)8.29%
ROICexcg growth 3Y-22.62%
ROICexcg growth 5Y-9.94%
ROICexc growth 3Y-22.6%
ROICexc growth 5Y-9.94%
OM growth 3Y-11.37%
OM growth 5Y-7.83%
PM growth 3Y-13.8%
PM growth 5Y-12.12%
GM growth 3Y-3.52%
GM growth 5Y-4.26%
F-Score5
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 6.71
Debt/EBITDA 8.63
Cap/Depr 0.78%
Cap/Sales 0.01%
Interest Coverage 1.49
Cash Conversion 178.92%
Profit Quality 302.57%
Current Ratio 2.03
Quick Ratio 0.72
Altman-Z 1.17
F-Score5
WACC5.48%
ROIC/WACC0.5
Cap/Depr(3y)7.38%
Cap/Depr(5y)21.47%
Cap/Sales(3y)0.08%
Cap/Sales(5y)0.18%
Profit Quality(3y)344.5%
Profit Quality(5y)286.9%
High Growth Momentum
Growth
EPS 1Y (TTM)32.58%
EPS 3Y-25.87%
EPS 5Y-16.52%
EPS Q2Q%-75.18%
EPS Next Y-4.12%
EPS Next 2Y20.54%
EPS Next 3Y20.37%
EPS Next 5Y30.79%
Revenue 1Y (TTM)-20.3%
Revenue growth 3Y-16.3%
Revenue growth 5Y-3.13%
Sales Q2Q%-18.28%
Revenue Next Year-11.66%
Revenue Next 2Y4.69%
Revenue Next 3Y6.3%
Revenue Next 5YN/A
EBIT growth 1Y-31.23%
EBIT growth 3Y-25.82%
EBIT growth 5Y-10.71%
EBIT Next Year9.86%
EBIT Next 3Y19.18%
EBIT Next 5YN/A
FCF growth 1Y704.53%
FCF growth 3Y34.2%
FCF growth 5YN/A
OCF growth 1Y703.43%
OCF growth 3Y32.65%
OCF growth 5YN/A